These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 26878648

  • 1. Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment.
    Jacobs R, Tshehla E, Malherbe S, Kriel M, Loxton AG, Stanley K, van der Spuy G, Walzl G, Chegou NN.
    Cytokine; 2016 May; 81():50-6. PubMed ID: 26878648
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response.
    Jacobs R, Malherbe S, Loxton AG, Stanley K, van der Spuy G, Walzl G, Chegou NN.
    Oncotarget; 2016 Sep 06; 7(36):57581-57592. PubMed ID: 27557501
    [Abstract] [Full Text] [Related]

  • 4. Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals.
    Manngo PM, Gutschmidt A, Snyders CI, Mutavhatsindi H, Manyelo CM, Makhoba NS, Ahlers P, Hiemstra A, Stanley K, McAnda S, Kidd M, Malherbe ST, Walzl G, Chegou NN.
    J Infect; 2019 Sep 06; 79(3):228-235. PubMed ID: 31319143
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis.
    Eribo OA, Leqheka MS, Malherbe ST, McAnda S, Stanley K, van der Spuy GD, Walzl G, Chegou NN.
    Int J Infect Dis; 2020 Oct 06; 99():473-481. PubMed ID: 32800854
    [Abstract] [Full Text] [Related]

  • 7. A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries.
    Chendi BH, Snyders CI, Tonby K, Jenum S, Kidd M, Walzl G, Chegou NN, Dyrhol-Riise AM.
    Front Immunol; 2021 Oct 06; 12():608846. PubMed ID: 33732236
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Candidate Biomarkers to Distinguish Spinal Tuberculosis From Mechanical Back Pain in a Tuberculosis Endemic Setting.
    Mann TN, Davis JH, Walzl G, Beltran CG, du Toit J, Lamberts RP, Chegou NN.
    Front Immunol; 2021 Oct 06; 12():768040. PubMed ID: 34868023
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential expression of host protein biomarkers among symptomatic clinic attendees finally diagnosed with tuberculosis and other respiratory diseases with or without latent Mycobacterium tuberculosis infection.
    Namuganga AR, Nsereko M, Bagaya BS, Mayanja-Kizza H, Chegou NN.
    Immunol Lett; 2023 Jan 06; 253():8-18. PubMed ID: 36463987
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG, Kang YA, Jang SH, Hong JY, Kim A, Lee SA, Kim Y, Cho SN.
    J Infect; 2015 Apr 06; 70(4):346-55. PubMed ID: 25452040
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis.
    Chegou NN, Sutherland JS, Namuganga AR, Corstjens PL, Geluk A, Gebremichael G, Mendy J, Malherbe S, Stanley K, van der Spuy GD, Kriel M, Loxton AG, Kriel B, Simukonda F, Bekele Y, Sheehama JA, Nelongo J, van der Vyver M, Gebrexabher A, Hailu H, Esterhuyse MM, Rosenkrands I, Aagard C, Kidd M, Kassa D, Mihret A, Howe R, Cliff JM, Crampin AC, Mayanja-Kizza H, Kaufmann SHE, Dockrell HM, Ottenhoff THM, Walzl G, AE-TBC consortium.
    Sci Rep; 2018 Feb 08; 8(1):2675. PubMed ID: 29422548
    [Abstract] [Full Text] [Related]

  • 17. Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.
    Jayakumar A, Vittinghoff E, Segal MR, MacKenzie WR, Johnson JL, Gitta P, Saukkonen J, Anderson J, Weiner M, Engle M, Yoon C, Kato-Maeda M, Nahid P, Tuberculosis Trials Consortium.
    Tuberculosis (Edinb); 2015 Jul 08; 95(4):415-20. PubMed ID: 26022314
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic accuracy of an integrated respiratory guideline in identifying patients with respiratory symptoms requiring screening for pulmonary tuberculosis: a cross-sectional study.
    English RG, Bachmann MO, Bateman ED, Zwarenstein MF, Fairall LR, Bheekie A, Majara BP, Lombard C, Scherpbier R, Ottomani SE.
    BMC Pulm Med; 2006 Aug 25; 6():22. PubMed ID: 16934140
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.